Marlies Michl

Praxis für Hämatologie und Onkologie — Germany

Medicine · Health Sciences

23h-index1.6kcitations67works7.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(20), Hepatocellular Carcinoma Treatment and Prognosis(11), Pancreatic and Hepatic Oncology Research(9), Gastric Cancer Management and Outcomes(9), Genetic factors in colorectal cancer(9)

Publications67 total

IDHIRA: a prospective, observational study on ivosidenib in patients with <i>IDH1</i> R132-mutated advanced cholangiocarcinoma
Future Oncology·2025Open Access
Evaluation of the inflammation-based modified Glasgow Prognostic Score (mGPS) as a prognostic and predictive biomarker in patients with metastatic colorectal cancer receiving first-line chemotherapy: a post hoc analysis of the randomized phase III XELAVIRI trial (AIO KRK0110)
ESMO Open·2024· 10 citedOpen Access
TGFβ signalling pathway impacts brain metastases profiles in locally advanced colorectal cancer
Clinical & Experimental Metastasis·2024· 1 citedOpen Access
Identification of a gene expression signature associated with brain metastasis in colorectal cancer
Clinical & Translational Oncology·2024· 7 citedOpen Access
PPARG activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracil
BMC Cancer·2024· 21 citedOpen Access
Long-Term Progression-Free Survival of a Pre-Treated Patient with Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil
Chemotherapy·2023· 1 citedOpen Access
Molekularpathologie kolorektaler Karzinome
Die Pathologie·2023· 6 cited
Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL
Cancers·2022· 10 citedOpen Access
Corrigendum to ‘Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial’. [European Journal of Cancer 137 (2020) 250–259]
European Journal of Cancer·2022· 1 cited
Expression of CIB1 correlates with colorectal liver metastases but not with peritoneal carcinomatosis
BMC Cancer·2021· 5 citedOpen Access
Outcome and Safety after 103 Radioembolizations with Yttrium-90 Resin Microspheres in 73 Patients with Unresectable Intrahepatic Cholangiocarcinoma—An Evaluation of Predictors
Cancers·2021· 26 citedOpen Access
Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer
Cellular and Molecular Gastroenterology and Hepatology·2021· 28 citedOpen Access
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first‐line treatment within the randomized Phase <scp>III</scp> trial <scp>FIRE</scp>‐3 (<scp>AIO KRK</scp>‐0306)
International Journal of Cancer·2021· 16 citedOpen Access
Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110)
European Journal of Cancer·2021· 14 citedOpen Access
Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin·2020· 11 citedOpen Access
Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival
International Journal of Cancer·2020· 27 citedOpen Access
Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial
European Journal of Cancer·2020· 25 cited
Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer
Cell Communication and Signaling·2020· 17 citedOpen Access
Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials
Journal of Cancer Research and Clinical Oncology·2020· 20 citedOpen Access
AIO-MentorUs – gelebte Nachwuchsförderung in der AIO
Forum·2020· 2 cited
page 1 of 4Next →

Frequent Co-authors

Volker Heinemann(36), Dominik Paul Modest(20), Thomas Kirchner(15), Sebastian Stintzing(14), Julian Walter Holch(13), Jens Neumann(13), Jobst C. von Einem(11), Ludwig Fischer von Weikersthal(10), Andreas Jung(9), Thomas Decker(8), Philipp M. Paprottka(7), Arndt Stahler(7), Michael Haas(6), Stefan Boeck(6), Rüdiger P. Laubender(6), Alexander Kiani(6), Tobias Heintges(6), Christoph Kahl(6), Frank Kullmann(6), Werner Scheithauer(6)